PNC Financial Services Group’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-46
Closed -$1.53K 4985
2024
Q3
$1.53K Buy
46
+6
+15% +$207 ﹤0.01% 4344
2024
Q2
$1.08K Hold
40
﹤0.01% 4405
2024
Q1
$864 Buy
+40
New +$872 ﹤0.01% 4395

PNC Financial Services Group's LBPH Position: Q4 2024 in Review

PNC Financial Services Group sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 46 shares — an estimated $1.53K sold.

PNC Financial Services Group first reported a position in LBPH in Q1 2024 and held it in 3 quarters. The position peaked at $1.53K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

  • PNC Financial Services Group reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 46 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $1.53K.
  • PNC Financial Services Group first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
  • PNC Financial Services Group's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $1.53K in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on PNC Financial Services Group's 13F filing for Q4 2024, filed 7 Feb 2025.